Items 31 to 40 of 253 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
(3S)-3-Hydroxy Quinidine | 53467-23-5 | sc-206741 | 1 mg | $265.00 | ||
(3S)-3-Hydroxy Quinidine is a notable metabolite distinguished by its capacity to engage in hydrogen bonding and π-π stacking interactions with nucleic acids and proteins. This compound undergoes specific enzymatic transformations, leading to the formation of reactive intermediates that can modulate cellular signaling pathways. Its unique stereochemistry influences its interaction dynamics, affecting reaction rates and stability in biological systems, thereby playing a role in metabolic regulation. | ||||||
Salicyl sulfate disodium salt | 56343-01-2 | sc-253528 | 5 mg | $350.00 | ||
Salicyl sulfate disodium salt is a distinctive metabolite characterized by its ability to form strong ionic interactions with various biomolecules, enhancing solubility and bioavailability. It participates in sulfation pathways, where it acts as a sulfate donor, influencing the metabolism of xenobiotics. The compound exhibits unique reaction kinetics, facilitating rapid conjugation reactions that can alter the reactivity of substrates, thereby impacting metabolic processes and cellular homeostasis. | ||||||
Omeprazole Sulfide | 73590-85-9 | sc-215632 | 25 mg | $191.00 | 1 | |
Omeprazole Sulfide is a notable metabolite that undergoes specific redox reactions, leading to the formation of reactive sulfur species. These species can engage in nucleophilic attacks on electrophilic centers in biomolecules, potentially modifying their structure and function. The compound's unique electron-donating properties enhance its reactivity, allowing it to participate in diverse metabolic pathways. Its stability in various pH environments further influences its interaction dynamics within biological systems. | ||||||
Pravastatin, Sodium Salt | 81131-70-6 | sc-203218 sc-203218A sc-203218B | 25 mg 100 mg 1 g | $68.00 $159.00 $772.00 | 2 | |
Pravastatin, Sodium Salt, is a significant metabolite characterized by its ability to modulate lipid metabolism through unique enzymatic interactions. It exhibits a distinct affinity for HMG-CoA reductase, influencing cholesterol biosynthesis pathways. The compound's solubility in aqueous environments enhances its bioavailability, facilitating its transport across cellular membranes. Additionally, its structural conformation allows for specific binding interactions, impacting downstream metabolic processes and regulatory mechanisms. | ||||||
Fumonisin B1 | 116355-83-0 | sc-201395 sc-201395A | 1 mg 5 mg | $117.00 $469.00 | 18 | |
Fumonisin B1 is a notable metabolite recognized for its interference with sphingolipid metabolism, particularly by inhibiting ceramide synthase. This disruption leads to altered cellular signaling and can affect cell proliferation and apoptosis. Its hydrophilic nature enhances solubility in biological systems, promoting its interaction with various cellular components. The compound's unique structural features facilitate specific binding to lipid membranes, influencing membrane integrity and function. | ||||||
5′-Hydroxy Meloxicam | 130262-92-9 | sc-207072 | 2.5 mg | $262.00 | 1 | |
5'-Hydroxy Meloxicam is a significant metabolite characterized by its unique interactions with cytochrome P450 enzymes, which play a crucial role in its biotransformation. This compound exhibits distinct kinetic properties, influencing its rate of metabolism and clearance in biological systems. Its polar functional groups enhance solubility, allowing for effective distribution within tissues. Additionally, its structural conformation enables specific interactions with protein targets, potentially modulating various biochemical pathways. | ||||||
A77 1726 | 163451-81-8 | sc-207235 | 10 mg | $78.00 | 14 | |
A77 1726 is a notable metabolite that engages in selective interactions with various enzyme systems, particularly influencing the activity of UDP-glucuronosyltransferases. Its unique structural features facilitate rapid conjugation reactions, enhancing its metabolic stability. The compound's hydrophilic characteristics promote efficient renal excretion, while its conformational flexibility allows for diverse binding affinities with biomolecules, potentially impacting metabolic pathways and cellular signaling. | ||||||
SN 38 | 86639-52-3 | sc-203697 sc-203697A sc-203697B | 10 mg 50 mg 500 mg | $117.00 $335.00 $883.00 | 19 | |
SN 38 is a significant metabolite characterized by its ability to form stable interactions with DNA and RNA, leading to the formation of covalent adducts. This compound exhibits unique reactivity patterns, particularly in its ability to undergo phase II metabolic processes, which enhance its solubility. Its distinct stereochemistry contributes to varied binding dynamics with cellular targets, influencing downstream signaling cascades and metabolic regulation. | ||||||
Hydroxy Bupropion | 357399-43-0 | sc-211604 | 10 mg | $266.00 | 5 | |
Hydroxy Bupropion is a notable metabolite that showcases unique binding affinities, particularly with neurotransmitter transporters. Its hydroxyl group enhances hydrogen bonding interactions, facilitating specific molecular recognition. The compound undergoes distinct metabolic pathways, including glucuronidation, which alters its pharmacokinetic profile. Additionally, its lipophilicity influences membrane permeability, affecting its distribution and interaction with cellular components. | ||||||
19-Hydroxy Cholesterol | 561-63-7 | sc-208882 | 5 mg | $200.00 | ||
19-Hydroxy Cholesterol is a significant metabolite involved in the regulation of cholesterol homeostasis. It participates in unique enzymatic pathways, particularly in the conversion to bile acids, influencing lipid metabolism. The compound exhibits distinct interactions with nuclear receptors, modulating gene expression related to lipid metabolism. Its structural features allow for specific binding to proteins, impacting cellular signaling and metabolic processes. Additionally, it plays a role in the feedback regulation of cholesterol synthesis. |